A Cardiac Liability Study of Varegacestat in Healthy Participants

Inclusion Criteria: * Healthy, adult, male or female (of non childbearing potential), 18 to 55 years of age, inclusive, at the screening visit. * Medically healthy with no clinically significant medical history, physical examination, clinical laboratory profiles, and vital signs, as deemed by the PI or designee Exclusion Criteria: * History of any illness that, in the opinion of the PI or designee, might confound the results of the study or pose an additional risk to the participant by their participation in the study. * Have taken an investigational drug or participated in a clinical trial evaluating an investigational drug or device within 30 days (or 5 half-lives) prior to the study drug dose, whichever is longer.